Lim V S, Yarasheski K E, Flanigan M J
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, USA.
Nephrol Dial Transplant. 1998 Jul;13(7):1723-30. doi: 10.1093/ndt/13.7.1723.
Uraemia and dialysis are viewed as catabolic processes resulting in malnutrition in chronic renal failure (CRF) patients. To sort out the effects of uraemia, acidosis, and dialysis on protein metabolism, we measured leucine flux in CRF patients before and after initiation of maintenance dialysis.
Whole-body leucine flux was measured by primed-constant infusion of L[1-(13)C] leucine in nine CRF patients longitudinally; twice before and once after initiation of maintenance dialysis (D). Before dialysis, one leucine flux was measured when the patients were acidotic (A), and the other, when acidosis was corrected with NaHCO, (NA). Five normal subjects underwent one single leucine flux measurement to serve as control (N). Both patients and normal subjects consumed a constant diet for 6 days and leucine flux was measured on the 7th day 12 h post-absorption. Diet for the CRF patients was identical during the three periods. Plasma L[1-(13)C] leucine and L[1-(13)C]KIC were measured by gas chromatography/mass spectrometry and expired 13CO2 by isotope ratio spectrometry. Leucine kinetics were calculated using standard equations.
Plasma CO2 levels were 19, 26 and 31 mmol/l in A, NA and D periods respectively. All kinetic results (micromol/kg/h) are presented as means +/- SD in the order of A, NA, D, and N, and CRF values that are statistically different from N are identified (). The amounts of leucine release from endogenous protein breakdown (Ra or Q) were 101 +/- 12 95 +/- 9* 113 +/- 22 and 117 +/- 6. Leucine oxidation (C), quantities of leucine irreversibly oxidized to CO2, were 16.5 +/- 5.4, 9.7 +/- 3.7*, 12.3 +/- 3.0*, and 23.2 +/- 3.1. Leucine protein incorporation levels (S) were 85 +/- 10, 85 +/- 8, 101 +/- 19 and 94 +/- 6. The S of 101 in CRF patients at period D was statistically higher than those during A and NA periods.
These data indicate that when acidosis was corrected, CRF patients adapted to lower protein intake by reducing amino-acid oxidation and protein degradation, and maintained protein synthesis at normal levels. Metabolic acidosis impaired the downregulation of amino-acid oxidation. Maintenance dialysis treatment longitudinally restored protein flux to normal and increased protein synthesis. The general notion that uraemia and dialysis are protein catabolic is not supported by this work.
尿毒症和透析被视为分解代谢过程,可导致慢性肾衰竭(CRF)患者营养不良。为了明确尿毒症、酸中毒和透析对蛋白质代谢的影响,我们测定了维持性透析开始前后CRF患者的亮氨酸通量。
对9例CRF患者纵向进行L-[1-(13)C]亮氨酸的初量-恒速输注以测定全身亮氨酸通量;维持性透析(D)开始前测定两次,开始后测定一次。透析前,在患者酸中毒(A)时测定一次亮氨酸通量,在用碳酸氢钠纠正酸中毒(NA)时测定另一次。5名正常受试者进行一次亮氨酸通量测定作为对照(N)。患者和正常受试者均连续6天食用固定饮食,并在吸收后12小时的第7天测定亮氨酸通量。CRF患者在三个时期的饮食相同。采用气相色谱/质谱法测定血浆L-[1-(13)C]亮氨酸和L-[1-(13)C]α-酮异己酸,采用同位素比质谱法测定呼出的13CO2。使用标准方程计算亮氨酸动力学。
A、NA和D期的血浆二氧化碳水平分别为19、26和31 mmol/L。所有动力学结果(微摩尔/千克/小时)按A、NA、D和N的顺序以平均值±标准差表示,与N有统计学差异的CRF值用标识。内源性蛋白质分解产生的亮氨酸释放量(Ra或Q)分别为101±12、95±9*、113±22和117±6。亮氨酸氧化(C),即不可逆氧化为二氧化碳的亮氨酸量,分别为16.5±5.4、9.7±3.7*、12.3±3.0*和23.2±3.1。亮氨酸掺入蛋白质的水平(S)分别为85±10、85±8、101±19和94±6。CRF患者在D期的S值101在统计学上高于A期和NA期。
这些数据表明,酸中毒纠正后,CRF患者通过减少氨基酸氧化和蛋白质降解来适应较低的蛋白质摄入量,并将蛋白质合成维持在正常水平。代谢性酸中毒损害了氨基酸氧化的下调。维持性透析治疗纵向将蛋白质通量恢复正常并增加了蛋白质合成。这项研究不支持尿毒症和透析是蛋白质分解代谢的普遍观点。